In a reversal of two decades of medical reports, a Mayo Clinic study finds the frequency of nerve damage called diabetic polyneuropathy is similar in prediabetic patients and healthy people….
Read More »Diabetes In Control
Self-monitoring Shows Significant Benefit for New Type 2’s
A new study contradicts previous studies showing no benefit to self-monitoring for new type 2’s, at least in the first year.…
Read More »Insulin as a Satiety Signal in Postprandial Period
Brain insulin may act as a satiety signal during the postprandial period and is associated with decreased appetite and reduced intake of highly palatable food….
Read More »Short-term Effects of Liraglutide on Visceral Fat Adiposity, Appetite, and Food Preference
Short-term treatment with liraglutide improved visceral fat adiposity, appetite, food preference and the urge for fat intake in obese Japanese patients with type 2 diabetes.…
Read More »Doctors Finally Advising Patients to Exercise
The number of doctors in the US telling patients to get physically active has increased in the past decade. New research shows that, in 2010 alone, one in three patients who visited a physician or other health professional had been told to start or maintain physical activity or exercise.…
Read More »Bolus Calculation, Flexible Insulin Ups Diabetes Control
A structured course teaching the benefits of automated bolus calculator use and flexible intensive insulin therapy improves metabolic control and satisfaction in patients with type 1 diabetes.…
Read More »Flavanones in Citrus Fruit Lower Stroke Risk
High intake of flavanones, a subclass of flavonoids found in the greatest concentrations in oranges and grapefruit, is associated with a 19% lower risk for ischemic stroke in women, a new analysis from the Nurses’ Health Study has shown.…
Read More »Dapagliflozin Reduces Body Fat in Diabetes Patients
A new study confirms dapagliflozin helps patients with type 2 diabetes lose a few pounds in addition to improving their blood sugar levels.… What’s noteworthy about the study, say the researchers, is that dapagliflozin leads to loss of fat mass, with significant reductions in both abdominal visceral adipose tissue and …
Read More »Editor’s Note #73: When Half of 12 is Not 6!
We have seen that many of our diabetes patients also have hypertension and or elevated lipids and are often referred to as suffering from cardiometabolic syndrome. Over the past couple of months, Stan Schwartz, MD, FACP, has been educating us on the diagnosis and treatment of this syndrome. He finishes …
Read More »Letter from the Editor #614: The Blood Sugar Roller Coaster
Last week I walked into the pharmacy and heard a call over the intercom, “Manager to deli, please.” I didn’t think anything of it until the manager called me back to the deli because one of his employees was lying on the floor with a glucose reading of 36mg/dl. We …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.